scholarly article | Q13442814 |
P50 | author | Ane Johannessen | Q56073351 |
P2093 | author name string | Gulsvik A | |
Bakke PS | |||
Omenaas ER | |||
P2860 | cites work | Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary | Q29614692 |
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 | ||
Gender differences in airway behaviour over the human life span | Q30496384 | ||
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study | Q30790513 | ||
Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response | Q33705194 | ||
Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study | Q34504296 | ||
The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease | Q35501556 | ||
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages | Q35536523 | ||
Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents | Q36253383 | ||
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study | Q39549815 | ||
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies | Q44809323 | ||
The GOLD classification has advanced understanding of COPD. | Q47950295 | ||
Population impact of different definitions of airway obstruction. | Q51655883 | ||
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. | Q51686318 | ||
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. | Q51696510 | ||
Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. | Q51700792 | ||
The relation of body mass index to asthma, chronic bronchitis, and emphysema. | Q51701187 | ||
Occupational airborne exposure and the incidence of respiratory symptoms and asthma. | Q51702037 | ||
Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? | Q51708631 | ||
Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. | Q53145189 | ||
Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population | Q58840363 | ||
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease | Q61875242 | ||
Performance evaluation of contemporary spirometers | Q68698424 | ||
Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study | Q72289086 | ||
Maximum likelihood estimation of the attributable fraction from logistic models | Q72610226 | ||
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update | Q73711410 | ||
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1 | Q79924377 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
P304 | page(s) | 842-847 | |
P577 | publication date | 2005-08-05 | |
P1433 | published in | Thorax | Q7796158 |
P1476 | title | Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study | |
P478 | volume | 60 |
Q23915116 | A case-control study of airways obstruction among construction workers |
Q35694483 | A comparative study of COPD burden between urban vs rural communities in northern Thailand |
Q30619543 | A score to predict short-term risk of COPD exacerbations (SCOPEX). |
Q36865717 | Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit |
Q27012096 | Ageing and the epidemiology of multimorbidity |
Q37783859 | An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease |
Q89970843 | Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults |
Q51541860 | Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population. |
Q36837701 | COPD prevalence in a random population survey: a matter of definition. |
Q23912728 | Case definitions for chronic obstructive pulmonary disease |
Q33931328 | Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions |
Q51606521 | Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis. |
Q36225551 | Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? |
Q35906564 | Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study |
Q37336211 | Defining chronic obstructive pulmonary disease in older persons |
Q36373826 | Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data |
Q33897221 | Do symptoms predict COPD in smokers? |
Q37792835 | Earlier diagnosis and earlier treatment of COPD in primary care. |
Q36099476 | Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function |
Q36568757 | Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. |
Q23922840 | Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010 |
Q36225974 | Feasible and simple exclusion criteria for pulmonary reference populations |
Q41449935 | Genetic Variants in the Hedgehog Interacting Protein Gene Are Associated with the FEV1/FVC Ratio in Southern Han Chinese Subjects with Chronic Obstructive Pulmonary Disease. |
Q36926621 | Global burden of COPD: risk factors, prevalence, and future trends |
Q38617511 | Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 |
Q39798721 | Impact of bronchodilator use on the prevalence of COPD in population-based samples |
Q57955658 | Impact of diagnostic criteria on the prevalence of COPD |
Q45387569 | Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care. |
Q34374230 | Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care. |
Q49963482 | Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort. |
Q53249129 | Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. |
Q37242230 | Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients |
Q89907103 | Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources |
Q35861330 | Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study. |
Q51135760 | Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey. |
Q41680089 | Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers. |
Q47143734 | Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot). |
Q43664449 | Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study. |
Q37300877 | Pragmatic research and outcomes in asthma and COPD |
Q33627627 | Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study. |
Q35451346 | Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study |
Q100473655 | Prediction of chronic heart failure and chronic obstructive pulmonary disease in a general population: the Tromsø study |
Q28387926 | Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study |
Q23910517 | Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010 |
Q37103925 | Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study |
Q39801292 | Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey |
Q44506625 | Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. |
Q33824058 | Proportional classifications of COPD phenotypes. |
Q43429950 | Psychometric properties of the Hospital Anxiety and Depression Scale and The General Health Questionnaire-20 in COPD inpatients. |
Q37412908 | Pulmonary complications after abdominal surgery in patients with mild-to-moderate chronic obstructive pulmonary disease |
Q27968911 | Pulmonary function among Latino thoroughbred horse farmworkers |
Q48758418 | Pulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients--especially in patients with mild or moderate disease. |
Q30496983 | Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey |
Q39632785 | Reversibility of airway obstruction vs bronchodilatation: do we speak the same language? |
Q58061937 | Significant Bronchodilator Responsiveness and “Reversibility” in a Population Sample |
Q39024368 | Spirometer Replacement and Serial Lung Function Measurements in Population Studies: Results From the SAPALDIA Study |
Q46227278 | Spirometry for detection of undiagnosed chronic obstructive pulmonary disease in primary care |
Q21093297 | Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema |
Q47099683 | The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms |
Q97568401 | The sputum microbiome is distinct between COPD and health, independent of smoking history |
Q42764411 | Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story |
Q37253026 | What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? |
Q84148874 | [Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities] |
Search more.